13,203 Shares in Cigna Group $CI Purchased by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC acquired a new stake in Cigna Group (NYSE:CI – Free Report) during the third quarter, HoldingsChannel.com reports. The fund acquired 13,203 shares of the health services provider’s stock, valued at approximately $3,589,000. Cigna Group accounts for about 2.2% of Sivik Global Healthcare LLC’s holdings, making the stock its 23rd largest position.

A number of other hedge funds have also bought and sold shares of the company. NorthCrest Asset Manangement LLC grew its holdings in Cigna Group by 37.6% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 12,133 shares of the health services provider’s stock worth $3,298,000 after acquiring an additional 3,313 shares during the period. Armstrong Advisory Group Inc. lifted its stake in shares of Cigna Group by 1,254.2% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 2,722 shares of the health services provider’s stock valued at $740,000 after purchasing an additional 2,521 shares during the period. Mirador Capital Partners LP acquired a new position in shares of Cigna Group in the 3rd quarter valued at about $2,466,000. GK Wealth Management LLC boosted its position in shares of Cigna Group by 9.7% during the 3rd quarter. GK Wealth Management LLC now owns 836 shares of the health services provider’s stock valued at $227,000 after purchasing an additional 74 shares in the last quarter. Finally, Wedmont Private Capital boosted its position in shares of Cigna Group by 26.1% during the 3rd quarter. Wedmont Private Capital now owns 11,623 shares of the health services provider’s stock valued at $3,159,000 after purchasing an additional 2,406 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of NYSE:CI traded down $0.22 during mid-day trading on Tuesday, reaching $283.12. The company had a trading volume of 479,565 shares, compared to its average volume of 1,667,322. Cigna Group has a one year low of $239.51 and a one year high of $311.34. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The company’s 50-day moving average price is $277.43 and its 200-day moving average price is $281.20. The firm has a market cap of $74.81 billion, a price-to-earnings ratio of 11.72, a PEG ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The company had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period in the previous year, the business earned $7.20 earnings per share. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts anticipate that Cigna Group will post 30.50 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 22,730 shares of company stock worth $6,293,359. 0.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Sanford C. Bernstein reissued an “outperform” rating on shares of Cigna Group in a research note on Friday, October 2nd. Wells Fargo & Company raised their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Wolfe Research reiterated an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Barclays boosted their target price on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Finally, Evercore started coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price on the stock. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $338.24.

View Our Latest Stock Analysis on CI

About Cigna Group

(Free Report)

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.